Webinar Date/Time: Tuesday, September 19th, 2023 at 8am PDT | 11am EDT | 4pm BST
What’s one area in which 50% of commercial forecasters believe their company could improve? Join us to discuss this and more findings from the second annual IQVIA Commercial Forecasting Survey.
Register Free: https://www.pharmexec.com/pe_w/commercial-forecasting
Event Overview:
Earlier this year, IQVIA launched its second annual Commercial Forecasting survey. Respondents included over 80 forecasters in the life sciences, in segments ranging from small biotech to large pharma and roles ranging from Analysts to VPs.
Join David Wolter and Alexandra Tataru for a discussion about the present and future of commercial forecasting based on the insights from this survey.
In this webinar, IQVIA will address questions such as:
Three key take-aways:
Speakers:
David Wolter
Vice President, IQVIA Commercial Consulting
IQVIA
David Wolter is a Vice President in IQVIA’s Commercial Consulting group. He has more than 18 years of experience in management consulting and modeling system development and is the co-lead of the US Corporate & Portfolio Strategy Center of Excellence. His past work has included product valuations, designing and developing forecasting models and web-based tools, analogue analyses, and decision-analysis/strategy projects. David has an MBA from Stanford GSB, an MS in Accounting from DePaul University and a BA in Economics from Amherst College.
Alexandra Tataru
Associate Principal, IQVIA Commercial Consulting
IQVIA
Alex Tataru is the product lead for IQVIA Forecast Horizon and has managed forecasting engagements with a wide range of clients. She has 10+ years of experiences in various healthcare fields, including management consulting, software design, and software implementation. She has an MBA from Columbia University and an MS in Mechanical engineering from Stanford University.
Register Free: https://www.pharmexec.com/pe_w/commercial-forecasting
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
November 14th 2024Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.